The genetic aspects of pre-eclampsia: Achievements and limitations

Biochemical Genetics

Volumn 46, Issue 7-8, 2008, Pages 451-479

  Nejatizadeh, Azim ^a   Stobdan, Tsering ^a   Malhotra, Neena ^b   Pasha, M A Qadar ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Association studies; Genetics; Linkage analysis; Polymorphism; Pre eclampsia; Pregnancy

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5 LEIDEN; BRADYKININ B2 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HLA A ANTIGEN; HLA B ANTIGEN; HLA D ANTIGEN; PROTEIN AT1 AA; PROTHROMBIN; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; BLOOD CLOTTING DISORDER; BLOOD VESSEL INJURY; CHROMOSOME ANALYSIS; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; EPIGENETICS; FAMILY STUDY; FETUS DEVELOPMENT; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOME IMPRINTING; HLA SYSTEM; HUMAN; HYPERTENSION; HYPOXIA; IMMUNE DEFICIENCY; IMMUNOREGULATION; MATERNAL MORTALITY; MATERNAL WELFARE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PLACENTA DEVELOPMENT; PREECLAMPSIA; PROTEIN INTERACTION; REGULATOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOX1 GENE; TROPHOBLAST; UTERUS;

CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; GENOMICS; HUMANS; LINKAGE (GENETICS); PRE-ECLAMPSIA; PREGNANCY; RENIN-ANGIOTENSIN SYSTEM;

EID: 46149093684     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-008-9163-9     Document Type: Review

References (145)

1. AbdAlla S, Lother H, Massiery A, Quitterer U (2001) Increased AT1 receptor heterodimers in pre-eclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7:1003-1009
2. Abdul-Karim R, Assalin S (1961) Pressor response to angiotonin in pregnant and non-pregnant women. Am J Obstet Gynecol 82:246-251
3. Ahsan A, Charu R, Norboo T, Afrin F, Baig MA, Pasha MAQ (2004) eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 59:1000-1002
4. Arngrímsson R (2005) Epigenetics of hypertension in pregnancy. Nat Genet 37:460-461
5. Arngrímsson R, Purandare S, Connor M, Walker JJ, Bjornsson S, Soubrier F, Kotelevtsev YV, Geirsson RT, Björnsson H (1993) Angiotensinogen: a candidate gene involved in pre-eclampsia? Nat Genet 4:114-115
6. Arngrímsson R, Geirsson RT, Cooke A, Connor M, Bjornsson S, Walker JJ (1994) Renin gene restriction fragment length polymorphisms do not show linkage with pre-eclampsia and eclampsia. Acta Obstet Gynecol Scand 73:10-13
7. Arngrímsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, Bjarnadóttir RI, Brock DJ, Geirsson RT, Connor JM, Soubrier F (1997) Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 61:354-362
8. Arngrímsson R, Sigurardttir S, Frigge ML, Bjarnadttir RI, Jonsson T, Stefansson H, Baldursdóttir A, Einarsdóttir AS, Palsson B, Snorradóttir S, Lachmeijer AM, Nicolae D, Kong A, Bragason BT, Gulcher JR, Geirsson RT, Stefánsson K (1999) A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 8:1799-1805
9. Bashford MT, Hefler LA, Vertrees TW, Roa BB, Gregg AR (2001) Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with pre-eclampsia. Am J Obstet Gynecol 184:1345-1350
10. Beer AE, Need JA (1985) Immunological aspects of pre-eclampsia/eclampsia. Birth Defects Orig Artic Ser 21:131-154
11. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
12. Boyg PA, Lindenbaum RH, Redman C (1987) Pre-eclampsia and trisomy 13: a possible association. Lancet 2:2425-2427
13. Brennecke SP, Gude NM, Di Iulio JL, King RG (1997) Reduction of placental nitric oxide synthase activity in pre-eclampsia. Clin Sci 93:51-55
14. Brink M, Erne P, de Gasparo M, Rogg H, Schmid A, Stulz P, Bullock G (1996) Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol 28:1789-1799
15. Bullock GR, Steyaert I, Bilbe G, Carey RM, Kips J, De Paepe B, Pauwels R, Praet M, Siragy HM, de Gasparo M (2000) Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol 115:117-124
16. Buttery LD, McCarthy A, Springall DR, Sullivan MH, Elder MG, Michel T, Polak JM (1994) eNOS in the human placenta; regional distribution and proposed regulatory role at the fetal-maternal interface. Placenta 15:257-265
17. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, Gomez R, Edwin S (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of pre-eclampsia. Young Investigator Award. Am J Obstet Gynecol 190:1541-1547
18. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH (1996) Tumor necrosis factor alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 104:154-159
19. Chesley LC (1984) History and epidemiology of preeclampsia-eclampsia. Clin Obstet Gynecol 27:801-820
20. Chesley LC (1993) The genetic of pre-eclampsia. Hypertens Pregnancy 12:7-10
21. Chesley LC, Cooper DW (1986) Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 93:898-908
22. Church WR, Jernigan RL, Toole J, Hewick RM, Knopf J, Knutson GJ, Nesheim ME, Mann KG, Fass DN (1984) Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. Proc Natl Acad Sci USA 81:6934-6937
23. Cooper DW, Liston WA (1979) Genetic control of severe pre-eclampsia. J Med Genet 167:409-416
24. Cooper DW, Brennecke SP, Wilton AN (1993) Genetics of pre-eclampsia. Hypertens Pregnancy 12:1-23
25. Cunningham FG, Lindheimer MD (1992) Hypertension in pregnancy. N Engl J Med 326:927-932
26. Dahlback B (1994) Inherited resistance to activated protein C: a major cause of venous thrombosis is due to a mutation in the factor V gene. Homeostasis 24:139-151
27. Dallinga-Thei G, Van Linde-Sibenius Trip M, Kock LA, De Bruin TW (1995) Apolipoprotein ε2/ε3/ε4 genotyping with agarose gels. Clin Chem 41:73-74
28. Dechend R, Viedt C, Müller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107:1632-1639
29. De Gasparo M, Whitebread S, Kalenga MK, De Hertogh R, Crevoisier P, Thomas K (1994) Down regulation of the angiotensin II receptor subtype AT2 in human myometrium during pregnancy. Regul Pept 53:39-45
30. Dekker G (2005) Prothrombotic mechanisms in pre-eclampsia. Thromb Res 115:17-21
31. Dekker GA, Robillard PY, Hulsey TC (1998) Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 53:377-382
32. Dekker GA, Sibai BM (1998) Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol 179:1359-1375
33. Dizon-Townson DS, Nelson LM, Easton K, Ward K (1996) The factor V leiden mutation may predispose women to severe pre-eclampsia. Am J Obstet Gynecol 175:902-905
34. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, Imaizumi T (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 11:267-275
35. Esplin MS, Fauselt MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW (2001) Paternal and maternal components of the predisposition to pre-eclampsia. N Engl J Med 344:867-872
36. Fisher RM, Humphries SE, Talmud PJ (1997) Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145-159
37. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor-1. Mol Cell Biol 16:4604-4613
38. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC (1973) A study of angiotensin II pressor response through primigravid pregnancy. J Clin Invest 52:2680-2682
39. Goldstein DP, Berkowiz RS (1994) Current management of complete and partial molar pregnancy. J Reprod Med 39:139-146
40. GOPEC Consortium (2005) Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 77:127-131
41. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Scianname N, Montanaro S, Paladini D, Martinelli P, Di Minno G (1999) Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost 81:349-352
42. Graves JA (1998) Genomic imprinting, development and disease-is pre-eclampsia caused by a maternally imprinted gene? Reprod Fertil Dev 10:23-29
43. Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW (1997) Angiotensinogen gene variation in a population case-control study of pre-eclampsia/eclampsia in Australians and Chinese. Electrophoresis 18:1646-1649
44. Guo G, Lade JA, Wilton AN, Moses EK, Grehan M, Fu Y, Qiu H, Cooper DW, Brennecke SP (1999) Genetic susceptibility to pre-eclampsia and chromosome 7q36. Hum Genet 105:641-647
45. Haig D (1993) Genetic conflicts in human pregnancy. Q Rev Biol 68:495-532
46. Haig D, Graham C (1991) Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64:1045-1046
47. Harrison GA, Humphrey KE, Jones N, Badenhop R, Guo G, Elakis G, Kaye JA, Turner RJ, Grehan M, Wilton AN, Brennecke SP, Cooper DW (1997) A genomewide linkage study of pre-eclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 60:1158-1167
48. Hayward C, Livingstone J, Holloway S, Liston WA, Brock DJ (1992) An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. Am J Hum Genet 50:749-757
49. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC (2007) Dysregulation of the circulating and tissue-based renin-angiotensin system in pre-eclampsia. Hypertension 49:604-611
50. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CWG, Carrington M, Trowsdale J, Moffett A (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of pre-eclampsia and reproductive success. J Exp Med 200:957-965
51. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51:605-612
52. Hubel CA, Roberts JM, Ferrell RE (1999) Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet 56:289-296
53. Humphrey KE, Harrison GA, Cooper DW, Wilton AN, Brennecke SP, Trudinger BJ (1995) HLA-G deletion polymorphism and pre-eclampsia/eclampsia. Br J Obstet Gynaecol 102:707-710
54. Hunt JS, Orr HT (1992) HLA and maternal-fetal recognition. FASEB J 6:2344-2348
55. Innes KE, Marshall JA, Byers TE, Calonge NA (1990) Woman's own birth weight and gestational age predict her later risk of developing pre-eclampsia, a precursor of chronic disease. Epidemiology 10:153-160
56. Inoue I, Rohrwasser A, Helin C, Jeunemaitre X, Crain P, Bohlender J, Lifton RP, Corvol P, Ward K, Lalouel JM (1995) A mutation of AGT in a patient with pre-eclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem 270:11430-11436
57. Inoue I, Nakajima T, Williams C, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription. J Clin Invest 99:1786-1797
58. Jikihara H, Poisner AM, Hirsch R, Handwerger S (1995) Human uterine decidual macrophages express renin. J Clin Endocrinol Metab 80:1273-1277
59. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Chen Y, Tabara Y, Yamamoto Y, Igase M, Bo X, Kohara K, Miki T (2003) Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 26:547-552
60. Kendall RL, Thomas KA (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705-10709
61. Kilpatrick DC (1999) Influence of human leukocyte antigen genes and tumor necrosis factor genes on the development of pre-eclampsia. Hum Reprod Update 5:94-102
62. Klonoff Cohen HS, Cross JL, Pieper CF (1996) Job stress and pre-eclampsia. Epidemiology 7:245-249
63. Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D (1999) A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 22:145-150
64. Koga K, Oruga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y (2003) Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with pre-eclampsia. J Clin Endocrinol Metab 88:2348-2351
65. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HLA G, expressed in human trophoblasts. Science 248:220-223
66. Kroeger KM, Carville KS, Abraham LJ (1997) The -308-tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391-399
67. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Eng J Med 340:9-13
68. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A (2000) High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 79:963-967
69. Laasanen J, Hiltunen M, Romppanen EL, Punnonen K, Mannermaa A, Heinonen S (2003) Microsatellite marker association at chromosome region 2p13 in Finnish patients with pre-eclampsia and obstetric cholestasis suggests a common risk locus. Eur J Hum Genet 11:232-236
70. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Frigge ML, Pals G, Sigurdardottir S, Stéfansson H, Pálsson B, Nicolae D, Kong A, Aarnoudse JG, Gulcher JR, Dekker GA, ten Kate LP, Stéfansson K (2001) A genome-wide scan for pre-eclampsia in the Netherlands. Eur J Hum Genet 9:758-764
71. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R (2002) Searching for pre-eclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 105:94-113
72. Lade JA, Moses EK, Guo G, Wilton AN, Grehan M, Cooper DW, Brennecke SP (1999) The eNOS gene: a candidate for the pre-eclampsia susceptibility locus? Hypertens Pregnancy 18:81-93
73. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K (2000) 677 C - >T polymorphism of the methylenetetrahydrofolate reductase gene and pre-eclampsia. Obstet Gynecol 96:277-280
74. Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, Laitinen T, Kaaja R, Ylikorkala O, Kere J (2003) Susceptibility loci for pre-eclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet 72:168-177
75. Lalouel JM, Rohrwasser A (2002) Power and replication in case-control studies. Am J Hypertens 15:201-205
76. Lanz B, Kadereit B, Ernst S, Shojaati K, Causevic M, Frey BM, Frey FJ, Mohaupt MG (2003) Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors. Kidney Int 64:970-977
77. Leung PS, Tsai SJ, Wallukat G, Leung TN, Lau TK (2001) The upregulation of angiotensin II type 1 receptor (AT1) in human preeclamptic placenta. Mol Cell Endocrinol 184:95-102
78. Levesque S, Moutquin JM, Lindsay C, Roy MC, Rousseau F (2004) Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 43:71-78
79. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA (2004) Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med 350:672-683
80. Lewis I, Lachmeijer G, Downing S, Dekker G, Glazebrook C, Clayton D, Morris NH, O'Shaughnessy KM (1999) Failure to detect linkage of pre-eclampsia to the region of the NOS3 locus on chromosome 7q. Am J Hum Genet 64:310-313
81. Lie RT, Rasmussen S, Brunborg H, Gjessing K, Lie-Nielsen E, Irgens LM (1998) Fetal and maternal contributions to the risk of pre-eclampsia: population-based study. BMJ 316:1343-1347
82. Matsumoto T, Sagawa N, Mukoyama M, Tanaka I, Itoh H, Goto M, Itoh H, Horiuchi M, Dzau VJ, Mori T, Nakao K (1996) Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down regulated during pregnancy. J Clin Endocrinol Metab 81:4366-4372
83. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA (2003) Excess placental soluble fmslike tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J Clin Invest 111:649-658
84. Mello G, Parretti E, Martini E, Mecacci F, La Torre P, Cioni R, Lucchetti R, Fedi S, Gori AM, Pepe G, Prisco D, Abbate R (1999) Usefulness of screening for congenital or acquired haemostatic abnormalities in women with previous complicated pregnancies. Homeostasis 24:147-203
85. Miettinen TA (1991) Impact of ApoE phenotype on the regulation of cholesterol metabolism. Ann Med 23:181-186
86. Morgan L, Baker P, Pipkin FB, Kalsheker N (1995) Pre-eclampsia and the angiotensinogen gene. Br J Obstet Gynaecol 102:489-490
87. Morgan L, Crawshaw S, Baker PN, Brookfield JF, Pipkin BF, Kalsheker N (1998) Distortion of maternal fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia. J Med Genet 35:632-636
88. Morgan T, Craven C, Nelson L, Lolouel JM, Ward K (1997) Angiotensinogen T235 variant expression is elevated in decidual spiral arteries. J Clin Invest 100:1406-1415
89. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP (2000) A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 67:1581-1585
90. Myatt L, Brewer A, Brockman DE (1991) The action of nitric oxide in the profused human fetal-placental circulation. Am J Obstet Gynecol 164:687-692
91. NHBPEP (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1-S22
92. O'Brien M, Dausset J, Carosella ED, Moreau P (1991) Analysis of the role of HLA-G in pre-eclampsia. Hum Immunol 146:2847-2854
93. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, Moreau P (2001) Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 58:1943-1949
94. Page EW (1939) The relation between hydatid moles, relative ischemia of the gravid uterus and the placental origin of eclampsia. Am J Obstet Gynecol 37:291-293
95. Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201-214
96. Pijnenborg R, Vercruysse L, Hanssens M, van Assche A (2003) Incomplete trophoblast invasion: the evidence. In: Critchley H, MacLean A, Poston L, Walker J (eds) Pre-eclampsia. RCOG Press, London, pp 15-26
97. Pipkin FB (1999) What is the place of genetic in the pathogenesis of pre-eclampsia? Biol Neonate 76:325-330
98. Raabe T, Bukrinsky M, Currie RA (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273:974-980
99. Redman CW (1991) Current topic: pre-eclampsia and the placenta. Placenta 12:301-308
100. Redman CW, Sargent IL (1993) The immunology of pre-eclampsia. In: Chaovat G (ed) Immunology of pregnancy. CRC Press, London, pp 205-230
101. Reid IA, Morris BJ, Ganong WF (1978) The renin-angiotensin system. Annu Rev Physiol 40:377-410
102. Risch N, Merikangas KR (1996) The future of genetic studies of complex human diseases. Science 273:1516-1517
103. Roberts JM (1998) Endothelial dysfunction in pre-eclampsia. Semin Reprod Endocrinol 16:5-15
104. Roberts JM (2000) Preeclampsia: what we know and what we do not know. Semin Perinatol 24:24-28
105. Roberts JM, Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357:53-56
106. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Pre-eclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204
107. Roberts JM, Edep ME, Goldfien A, Taylor RN (1992) Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol 27:101-108
108. Ros HS, Cnattingivs S, Lipworth L (1998) Comparison of risk factors for pre-eclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 147:1062-1070
109. Rosenblatt DS, Scriver CR, Beaudet AL, Sly WS, Valle D (1995) Inherited disorders of folate transport and metabolism. The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 3111-3128
110. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ (1997) Lipoprotein subfraction concentrations in pre-eclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 80:403-408
111. Sechi LA, Grady EF, Griffin CA, Kalinyak JE, Schambelan M (1992) Distribution of angiotensin II receptor subtypes in rat and human kidney. Am J Physiol 262:236-240
112. Show KJ, Do YS, Kjos S, Anderson PN, Shinagawa T, Dubeau L, Hsveh WA (1989) Human deciduas are a major source of renin. J Clin Invest 83:2085-2092
113. Siest G, Pillot T, Regis-Baill A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 41:1068-1086
114. Skoog T, Van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A (1999) A common functional polymorphism (C/A substitution at position -863) in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8:1443-1449
115. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T (1997) Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 34:525-526
116. Sowers JR, Eggana P, Kowal DK (1993) Expression of renin and angiotensinogen genes in preeclamptic and normal placental tissue. Clin Exp Hypertens 12:163-171
117. Steckelings UM, Bottari SP, Unger T (1992) Angiotensin receptor subtypes in the brain. Trends Pharmacol Sci 13:365-368
118. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sflt-1) induces proteinuria. J Biol Chem 278:12605-12608
119. Sutherland A, Cooper DW, Howie PW, Liston WA, MacGillivray I (1981) The incidence of severe pre-eclampsia amongst mothers and mother-in-law of preeclamptics and controls. Br J Obstet Gynaecol 88:785-791
120. Svensson PJ, Dahlback B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522
121. Tempfer CB, Dorman K, Deter RL, O'Brien WE, Gregg AR (2001) An endothelial nitric oxide synthase gene polymorphism is associated with pre-eclampsia. Hypertens Pregnancy 20:107-118
122. Thway TM, Shlykov SG, Day MC, Sanborn BM, Gilstrap LC, Xia Y, Kellems RE (2004) Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 110:1612-1619
123. Trupin LS, Simon LP, Eskinozi B (1996) Change of paternity: a risk factor for pre-eclampsia in multiparas. Epidemiology 7:240-244
124. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, Schaaps JP, Cabrol D, Frankenne F, Foidart JM (2003) Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88:5555-5563
125. Van Dijk M, Mulders J, Poutsma A, Konst AA, Lachmeijer AM, Dekker GA, Blankenstein MA, Oudejans CB (2005) Maternal segregation of the Dutch pre-eclampsia locus at 10q22 with a new member of the winged helix gene family. Nat Genet 37:514-519
126. Van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM, Buller HR (1999) High prevalence of hemostatic abnormalities in women with a history of severe pre-eclampsia. Am J Obstet Gynecol 180:1146-1150
127. Ventura SJ, Martin JA, Curtin SC, Menacker F, Hamilton BE (2001) Births: final data for 1999. Natl Vital Stat Rep 49:1-100
128. Walker JJ (2000) Pre-eclampsia. Lancet 356:1260-1265
129. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC (1999) Patients with pre-eclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103:945-952
130. Walther T, Menrad A, Orzechowski HD, Siemeister G, Paul M, Schirner M (2003) Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J 14:2061-2067
131. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss HP, Faber R, Stepan H (2005) Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 46:1275-1279
132. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP Lalouel J-M (1993) A molecular variant of angiotensinogen associated with pre-eclampsia. Nat Genet 4:59-61
133. Whitebread S, Mele M, Kamber B, De Gasparo M (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163:284-291
134. WHO (1987) The hypertensive disorders of pregnancy. World Health Organization Technical Report Series. World Health Organization, Geneva, p 758
135. Williams MA, Sanchez SE, Zhang C, Bazul V (2004) Methylenetetrahydrofolate reductase 677 C-T polymorphism and plasma folate in relation to pre-eclampsia risk among Peruvian women. J Matern Fetal Neonatal Med 15:337-344
136. Wilson AG, De Vries N, Pociot F, Di Giovine FS, Van der Putte LB, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560
137. Wilton AN, Cooper DW, Brennecke SP, Bishop SM, Marshall P (1990) Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLADRB. Lancet 336:653-657
138. Wilton AN, Barendse WJ, Donald JA, Marshall P, Trudinger B, Gallery ED, Brennecke SP, Cooper DW (1991) HLA-DRB types in pre-eclampsia and eclampsia. Tissue Antigens 38:137-141
139. Wilton AN, Kaye JA, Guo G, Brennecke SP, Cooper DW (1995) Is angiotensinogen a good candidate gene for pre-eclampsia? Hypertens Pregnancy 14:251-260
140. Xia Y, Wen H, Bobst S, Day MC, Kellems RE (2003) Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 10:82-93
141. Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y, Saito Y, Nakao K, Yasue H, Okamura H (2000) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe pre-eclampsia. J Soc Gynecol Investig 7:238-241
142. Zhang J, Klebanoff MA, Roberts JM (2001) Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet Gynecol 97:261-267
143. Zhou CC, Ahmad S, Mi T, Xia L, Abbasi S, Hewett PW, Sun CX, Ahmed A, Kellems RE, Xia Y (2007) Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 100:88-95
144. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe pre-eclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160:1405-1423
145. Zhuo J, Dean R, MacGregor D, Alcorn D, Mendelsohn FA (1996) Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature. Clin Exp Pharmacol Physiol 3:S147-S154